Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-05-19 @ 6:11 PM
Study NCT ID:
NCT00191334
Status:
COMPLETED
Last Update Posted:
2009-03-27
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine in Ovarian Cancer
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
9340
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Eli Lilly